ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 215 filers reported holding ICU MED INC in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $476 | -90.8% | 4 | -86.2% | 0.00% | -100.0% |
| Q2 2023 | $5,168 | +8.0% | 29 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $4,784 | +4.8% | 29 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $4,567 | +128.4% | 29 | +123.1% | 0.00% | – |
| Q2 2022 | $2,000 | -66.7% | 13 | -50.0% | 0.00% | -100.0% |
| Q1 2022 | $6,000 | -40.0% | 26 | -36.6% | 0.00% | -50.0% |
| Q4 2021 | $10,000 | +100.0% | 41 | +95.2% | 0.00% | +100.0% |
| Q3 2021 | $5,000 | -37.5% | 21 | -44.7% | 0.00% | -50.0% |
| Q2 2021 | $8,000 | +60.0% | 38 | +46.2% | 0.00% | +100.0% |
| Q1 2021 | $5,000 | 0.0% | 26 | +8.3% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +25.0% | 24 | +14.3% | 0.00% | 0.0% |
| Q3 2020 | $4,000 | 0.0% | 21 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $4,000 | -50.0% | 21 | -46.2% | 0.00% | -66.7% |
| Q1 2020 | $8,000 | +60.0% | 39 | +34.5% | 0.00% | +50.0% |
| Q4 2019 | $5,000 | +66.7% | 29 | +52.6% | 0.00% | +100.0% |
| Q3 2019 | $3,000 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PURA VIDA INVESTMENTS, LLC | 57,500 | $10,686,000 | 3.13% |
| Prospect Capital Advisors, LLC | 30,800 | $5,724,000 | 3.08% |
| Elk Creek Partners, LLC | 188,348 | $35,004,000 | 2.20% |
| Redmile Group, LLC | 201,750 | $37,495,000 | 1.85% |
| GW&K Investment Management, LLC | 495,259 | $92,044,000 | 1.53% |
| Lyon Street Capital, LLC | 18,724 | $3,480,000 | 1.34% |
| GAM Holding AG | 155,000 | $28,807,000 | 1.22% |
| Atika Capital Management LLC | 16,000 | $2,973,000 | 0.85% |
| Champlain Investment Partners, LLC | 375,170 | $69,725,000 | 0.82% |
| DIXON HUBARD FEINOUR & BROWN INC/VA | 14,995 | $2,787,000 | 0.80% |